An etiopathogenic role for the type I IFN system in SLE. (Q34319930)

1 August 2017

1 reference

title

An etiopathogenic role for the type I IFN system in SLE. (English)

1 reference

1 August 2017

Rönnblom L

1

1 reference

1 August 2017

Alm GV

series ordinal

2

1 reference

1 August 2017

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

22

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

427-431

1 reference

The genetics of systemic lupus erythematosus

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Environmental lupus syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Immune Interferon in the Circulation of Patients with Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Serum interferon levels in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

The type I interferon receptor: structure, function, and evolution of a family business.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Type I interferons keep activated T cells alive

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

IFN-alpha and IFN-beta: a link between immune memory and chronic inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Type I interferons and the Th1/Th2 paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

The function of type I interferons in antimicrobial immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Human natural interferon-alpha producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Stimulation of natural interferon-alpha/beta-producing cells by Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Properties of human natural interferon-producing cells stimulated by tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Interferons and the Colony-Stimulating Factors IL-3 and GM-CSF Enhance the IFN-alpha Response in Human Blood Leucocytes Induced by Herpes Simplex Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

The induction of interferon-alpha and interferon-beta mRNA in human natural interferon-producing blood leukocytes requires de novo protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

The cell surface phenotype of human natural interferon-alpha producing cells as determined by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

The nature of the principal type 1 interferon-producing cells in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Herpes simplex virus induces appearance of interferon-alpha/beta-producing cells and partially interferon-alpha/beta-dependent accumulation of leukocytes in murine regional lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Interferon-alpha production and tissue localization of interferon-alpha/beta producing cells after intradermal administration of Aujeszky's disease virus-infected cells in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Immunosuppressive effects of apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Etiopathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Cytokines and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

Molecular aberrations in human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901955-X

7 January 2021

10.1016/S1471-4906(01)01955-X

Identifiers

DOI

1 reference

1 August 2017

1 reference